Maternal and fetal complications in pregnancies with eclampsia in Ghaem hospital: June 2018 to June 2020

Document Type : Original Article

Authors

1 Assistant Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 General physician, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Associate Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

4 Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

5 Assistant Professor, Department of Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Introduction: Eclampsia is defined as generalized tonic-clonic seizure in a pregnant woman with preeclampsia. Eclampsia is one of the leading causes of maternal and fetal mortality worldwide. This study was performed with aim to evaluate maternal and fetal complications in pregnancies with eclampsia in Ghaem Hospital of Mashhad.
Methods: In this cross-sectional study, all patients with a diagnosis of eclampsia who were admitted to Ghaem Hospital between June 2018 and June 2020 were included in the study. Maternal and fetal complications were assessed. For all patients, a checklist was completed by the researcher including information and history of underlying diseases, surgery, obstetrics, and maternal and neonatal complications. Data were analyzed by SPSS statistical software (version 16).
Results: In this study, 51 patients with eclampsia were evaluated. The frequency percentage of eclampsia in Ghaem Hospital was 0.45%. Eclampsia before delivery was 66.7% and was higher than during and after delivery. Maternal complications included: increased rate of cesarean section (70%), postpartum bleeding (1.96%), liver disorders (1.96%), PRES syndrome (13.7%), HELLP syndrome (9.8%), DIC (1.96%), placental abruption (3.9%) and pulmonary edema (1.96%). Fetal complications were low Apgar (43.1%), low birth weight (41.1%), NICU admission (33.3%), preterm delivery (25.4%), IUGR (19.6%) and neonatal and fetal deaths (27.5%) that 4 cases were stillbirth and 10 cases died up to 7 days after birth. There was no maternal death.
Conclusion: Maternal complications were: preterm pregnancy, cesarean section due to placental abruption or IUGR, HELLP syndrome, ICU hospitalization and maternal death, respectively. Fetal complications were: preterm delivery, IUGR and NICU hospitalization and intrauterine fetal death, respectively.

Keywords

References

  1. Duley L. The global impact of pre-eclampsia and eclampsia. InSeminars in perinatology 2009; 33(3):130-37.
  2. Cruse D, Chennu S, Chatelle C, Bekinschtein TA, Fernández-Espejo D, Pickard JD, et al. Bedside detection of awareness in the vegetative state: a cohort study. The Lancet 2011; 378(9809):2088-94.
  3. Saghafi N, Pourali L, Ghanbarabadi VG, Mirzamarjani F, Mirteimouri M. Serum heat shock protein 70 in preeclampsia and normal pregnancy: A systematic review and meta-analysis. International Journal of Reproductive BioMedicine 2018; 16(1):1.
  4. Kashanian M, Kouhpayehzadeh Esfahani J, Eshraghi N, Jabbarpour Azari N. Effect of magnesium sulfate on blood coagulation status in pregnant women with preeclampsia. Iran J Obstet Gynecol Infertil 2021; 23(12):1-5.
  5. Farzaneh F, Tavakolikia Z, Soleimanzadeh Mousavi SH. Assessment of occurrence of preeclampsia and some clinical and demographic risk factors in Zahedan city in 2017. Clinical and Experimental Hypertension 2019; 41(6):583-8.
  6. Hemmatipur A, Jahangiri Mehr A, Touriaie E, Salehi Kombu M. Preeclampsia neonatal outcome in pregnant women with and without gestational diabetes mellitus and polycystic ovary syndrome. Iran J Obstet Gynecol Infertil 2018; 21(5):47-57.
  7. Lever AF, Harrap SB. Essential hypertension: a disorder of growth with origins in childhood?. Journal of hypertension 1992; 10(2):101-20.
  8. Dahmus MA, Barton JR, Sibai BM. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. American journal of obstetrics and gynecology 1992; 167(4):935-41.
  9. Mattar F, Sibai BM. EclampsiaVIII. Risk factors for maternal morbidity. American journal of obstetrics and gynecology 2000; 182(2):307-12.
  10. Singhal AB, Kimberly WT, Schaefer PW, Hedley-Whyte ET. Case 8-2009: a 36-year-old woman with headache, hypertension, and seizure 2 weeks post-partum. New England Journal of Medicine 2009; 360(11):1126-37.
  11. Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstetrics & Gynecology 2011; 118(5):1102-7.
  12. Tara F, Mansouri A, Mirzaiean S, Niazmand F, Karimi A, Jafarzadeh A. Analgesic Effect of Rectal Indomethacin on Pain after Cesarean Section.  Iran J Obstet Gynecol Infertil 2013; 16(80):1-5.
  13. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. InSeminars in perinatology 2012; 36(1):56-59.
  14. AbouZahr C, Wardlaw T. Maternal mortality at the end of a decade: signs of progress?. Bulletin of the world Health Organization 2001; 79:561-73.
  15. ALyassin A, Abediasl ZH, Qahsny M, Khademi A. The value of prenatal care in women with preeclampsia and eclampsia Shariati Hospital. Tehran University of Medical Sciences Journal 2002; 60(4):283-8.
  16. Mahran A, Fares H, Elkhateeb R, Ibrahim M, Bahaa H, Sanad A, et al. Risk factors and outcome of patients with eclampsia at a tertiary hospital in Egypt. BMC pregnancy and childbirth 2017; 17(1):1-7.
  17. Patel PC, Kathawadia KK, Saini HB. A Study of Fetomaternal Outcome in Eclampsia-A Case Control Study. National Journal Of Medical Research: 5.
  18. Ghosh MD, Singh V, Ray A. Maternal and foetal outcome of eclampsia in a referral hospital. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2017; 6(3):1021-5.
  19. Sultana R, Bashir R, Khan B. Presentation and management outcome of eclampsia at Ayub Teaching Hospital, Abbottabad. Hypertension 2005; 62:9-17.
  20. Ghomian N, Lotfalizade M, Movahedian A. Comparative study of serum level of vitamin D in pregnant women with preeclampsia and normal pregnant women. Iran J Obstet Gynecol Infertil 2015; 18(140):1-6.
  21. Adamu A. Pregnancy outcome in women with eclampsia at a tertiary centre in northern Nigeria. African journal of medicine and medical sciences 2012; 41(2):211-9.
  22. Olatunji AO, Sule-Odu AO. Presentation and outcome of eclampsia at a Nigerian University Hospital. Nigerian journal of clinical practice 2007; 10(1):1-4.
  23. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstetrics & Gynecology 2005; 105(2):402-10.
  24. Ade-Ojo IP, Loto OM. Outcome of eclampsia at the Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife. Nigerian journal of clinical practice 2008; 11(3):279-84.
  25. Shaheen B, Hassan L, Obaid M. Eclampsia, a major cause of maternal and perinatal mortality: a prospective analysis at a tertiary care hospital of Peshawar. Journal-Pakistan Medical Association 2003; 53(8):346-9.
  26. Arora R, Swain S, Agrawal A, Habeebullah S. Impact of mode of delivery on maternal mortality in eclampsia. Journal of the Indian Medical Association 1997; 95(4):103-4.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 25, Issue 1
March 2022
Pages 20-28

Files

Share

How to cite

Statistics